Iron imaging in myocardial infarction reperfusion injury.
Brianna F MoonSrikant Kamesh IyerEileen HwuangMichael P SolomonAnya T HallRishabh KumarNicholas J JosselynElizabeth M Higbee-DempseyAndrew TsourkasAkito ImaiKeitaro OkamotoYoshiaki SaitoJames J PillaJoseph H GormanRobert C GormanCory TschabrunnSamuel J KeeneyEstibaliz CastilleroGiovanni FerrariSteffen JockuschFelix W WehrliHaochang ShouVictor A FerrariYuchi HanAvanti GulhaneHarold LittWilliam MatthaiWalter R WitscheyPublished in: Nature communications (2020)
Restoration of coronary blood flow after a heart attack can cause reperfusion injury potentially leading to impaired cardiac function, adverse tissue remodeling and heart failure. Iron is an essential biometal that may have a pathologic role in this process. There is a clinical need for a precise noninvasive method to detect iron for risk stratification of patients and therapy evaluation. Here, we report that magnetic susceptibility imaging in a large animal model shows an infarct paramagnetic shift associated with duration of coronary artery occlusion and the presence of iron. Iron validation techniques used include histology, immunohistochemistry, spectrometry and spectroscopy. Further mRNA analysis shows upregulation of ferritin and heme oxygenase. While conventional imaging corroborates the findings of iron deposition, magnetic susceptibility imaging has improved sensitivity to iron and mitigates confounding factors such as edema and fibrosis. Myocardial infarction patients receiving reperfusion therapy show magnetic susceptibility changes associated with hypokinetic myocardial wall motion and microvascular obstruction, demonstrating potential for clinical translation.
Keyphrases
- high resolution
- heart failure
- iron deficiency
- coronary artery
- blood flow
- acute myocardial infarction
- left ventricular
- end stage renal disease
- cerebral ischemia
- acute ischemic stroke
- coronary artery disease
- molecularly imprinted
- chronic kidney disease
- squamous cell carcinoma
- cell proliferation
- signaling pathway
- emergency department
- mass spectrometry
- neoadjuvant chemotherapy
- climate change
- radiation therapy
- prognostic factors
- mesenchymal stem cells
- poor prognosis
- patient reported outcomes
- long non coding rna
- pulmonary arterial hypertension
- patient reported
- percutaneous coronary intervention
- human health